Author reviews the pathophysiology of obesity including the role of incretin hormones and the mechanism of action, efficacy, and safety of GLP-1 receptor agonists as antiobesity medications.
A team of researchers examined the effects on the microbiome from daily long-term consumption of high-protein, drained yogurt in women with overweight and obesity.
While food insecurity is a leading public health issue, research shows that nutrition security may be a better target for disease prevention strategies.
The aim of the study was to identify individuals with food insecurity and establish processes to refer patients and families to federal and community resources.
Intermittent fasting produces similar weight loss as traditional diets and is generally safe, producing few gastrointestinal, neurologic, hormonal, or metabolic effects.
A cross-sectional study was conducted to examine the relationship between body composition, physical fitness, and cardiovascular risk factors in childhood.
Investigators compared rates of diabetes, hypertension, and hyperlipidemia medication discontinuation in patients who underwent gastric bypass vs sleeve gastrectomy.
Intermittent fasting has demonstrated health benefits in a number of randomized clinical trials. Researchers sough to directly link specific health outcomes from these trials in people with overweight or obesity.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist primarily used to improve glycemic control in adults with type 2 diabetes. One favorable side effect of semaglutide is weight loss, and researchers have now studied its use in adults with overweight or obesity and without diabetes.
Approximately 5% to 10% of shift workers, including many health care professionals, have shift work disorder, a circadian sleep-wake cycle disorder defined by poor quality sleep.
